Pablo Artigas

Pablo Artigas

Auto-generated profile, based on publicly available information

Pablo Artigas

Department of Cell Physiology and Molecular Biophysics, Center for Membrane Protein Research, Texas Tech University Health Sciences Center, Lubbock, TX 79430

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2021 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
EBElisa D. Biondo
Elisa D. Biondo
KSKerri Spontarelli
Kerri Spontarelli
GAGiovanna Ababioh
Giovanna Ababioh
LMLois Méndez
Lois Méndez
PAPablo Artigas
Pablo Artigas
Human cell survival requires function of the Na+/K+ pump; the heteromeric protein that hydrolyzes ATP to extrude Na+ and import K+ across the plasmalemma, thereby building and maintaining these ions’ electrochemical gradients. Numerous dominant diseases caused by mutations in genes encoding for Na+/K+ pump catalytic (α) subunit isoforms highlight the importance of this protein. Here, we review literature describing disorders caused by missense mutations in ATP1A1, the gene encoding the ubiquitously expressed α1 isoform of the Na+/K+ pump. These various maladies include primary aldosteronism with secondary hypertension, an endocrine syndrome, Charcot-Marie-Tooth disease, a peripheral neuropathy, complex spastic paraplegia, another neuromuscular disorder, as well as hypomagnesemia accompanied by seizures and cognitive delay, a condition affecting the renal and central nervous systems. This article focuses on observed commonalities among these mutations’ functional effects, as well as on the special characteristics that enable each particular mutation to exclusively affect a certain system, without affecting others. In this respect, it is clear how somatic mutations localized to adrenal adenomas increase aldosterone production without compromising other systems. However, it remains largely unknown how and why some but not all de novo germline or familial mutations (where the mutant must be expressed in numerous tissues) produce a specific disease and not the other diseases. We propose hypotheses to explain this observation and the approaches that we think will drive future research on these debilitating disorders to develop novel patient-specific treatments by combining the use of heterologous protein-expression systems, patient-derived pluripotent cells, and gene-edited cell and mouse models.

1 November 2015 in Biophysical Journal
Verified
Journal Article
Closed access
CSChristopher Martin Stanley
Christopher Martin Stanley
DGDominique G. Gagnon
Dominique G. Gagnon
ABAdam Bernal
Adam Bernal
DMDylan J. Meyer
Dylan J. Meyer
JRJoshua J. Rosenthal
Joshua J. Rosenthal
PAPablo Artigas
Pablo Artigas

10 March 2021 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
JYJohn Q. Yap
John Q. Yap
JSJaroslava Seflova
Jaroslava Seflova
RSRyan Sweazey
Ryan Sweazey
PAPablo Artigas
Pablo Artigas
SRSeth L. Robia
Seth L. Robia
The sodium/potassium-ATPase (NKA) is the enzyme that establishes gradients of sodium and potassium across the plasma membrane. NKA activity is tightly regulated for different physiological contexts through interactions with single-span transmembrane peptides, the FXYD proteins. This diverse family of regulators has in common a domain containing a Phe-X-Tyr-Asp (FXYD) motif, two conserved glycines, and one serine residue. In humans, there are seven tissue-specific FXYD proteins that differentially modulate NKA kinetics as appropriate for each system, providing dynamic responsiveness to changing physiological conditions. Our understanding of how FXYD proteins contribute to homeostasis has benefitted from recent advances described in this review: biochemical and biophysical studies have provided insight into regulatory mechanisms, genetic models have uncovered remarkable complexity of FXYD function in integrated physiological systems, new posttranslational modifications have been identified, high-resolution structural studies have revealed new details of the regulatory interaction with NKA, and new clinical correlations have been uncovered. In this review, we address the structural determinants of diverse FXYD functions and the special roles of FXYDs in various physiological systems. We also discuss the possible roles of FXYDs in protein trafficking and regulation of non-NKA targets.

24 November 2020 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
DMDylan J. Meyer
Dylan J. Meyer
SBSharan Bijlani
Sharan Bijlani
MSMarilina de Sautu
Marilina de Sautu
KSKerri Spontarelli
Kerri Spontarelli
VYVictoria C. Young
Victoria C. Young
PAPablo Artigas
Pablo Artigas
Tight regulation of the Na/K pump is essential for cellular function because this heteromeric protein builds and maintains the electrochemical gradients for Na+ and K+ that energize electrical signaling and secondary active transport. We studied the regulation of the ubiquitous human α1β1 pump isoform by five human FXYD proteins normally located in muscle, kidney, and neurons. The function of Na/K pump α1β1 expressed in Xenopus oocytes with or without FXYD isoforms was evaluated using two-electrode voltage clamp and patch clamp. Through evaluation of the partial reactions in the absence of K+ but presence of Na+ in the external milieu, we demonstrate that each FXYD subunit alters the equilibrium between E1P(3Na) and E2P, the phosphorylated conformations with Na+ occluded and free from Na+, respectively, thereby altering the apparent affinity for Na+. This modification of Na+ interaction shapes the small effects of FXYD proteins on the apparent affinity for external K+ at physiological Na+. FXYD6 distinctively accelerated both the Na+-deocclusion and the pump-turnover rates. All FXYD isoforms altered the apparent affinity for intracellular Na+ in patches, an effect that was observed only in the presence of intracellular K+. Therefore, FXYD proteins alter the selectivity of the pump for intracellular ions, an effect that could be due to the altered equilibrium between E1 and E2, the two major pump conformations, and/or to small changes in ion affinities that are exacerbated when both ions are present. Lastly, we observed a drastic reduction of Na/K pump surface expression when it was coexpressed with FXYD1 or FXYD6, with the former being relieved by injection of PKA's catalytic subunit into the oocyte. Our results indicate that a prominent effect of FXYD1 and FXYD6, and plausibly other FXYDs, is the regulation of Na/K pump trafficking.

8 September 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
SYSiddhartha Yaragatupalli
Siddhartha Yaragatupalli
JOJ. Fernando Olivera
J. Fernando Olivera
CGCraig Gatto
Craig Gatto
PAPablo Artigas
Pablo Artigas
The Na/K pump actively exports 3 Na(+) in exchange for 2 K(+) across the plasmalemma of animal cells. As in other P-type ATPases, pump function is more effective when the relative affinity for transported ions is altered as the ion binding sites alternate between opposite sides of the membrane. Deletion of the five C-terminal residues from the alpha-subunit diminishes internal Na(+) (Na(i)(+)) affinity approximately 25-fold [Morth et al. (2007) Nature 450:1043-1049]. Because external Na(+) (Na(o)(+)) binding is voltage-dependent, we studied the reactions involving this process by using two-electrode and inside-out patch voltage clamp in normal and truncated (DeltaKESYY) Xenopus-alpha1 pumps expressed in oocytes. We observed that DeltaKESYY (i) decreased both Na(o)(+) and Na(i)(+) apparent affinities in the absence of K(o)(+), and (ii) did not affect apparent Na(o)(+) affinity at high K(o)(+). These results support a model of strict sequential external release of Na(+) ions, where the Na(+)-exclusive site releases Na(+) before the sites shared with K(+) and the DeltaKESYY deletion only reduces Na(o)(+) affinity at the shared sites. Moreover, at nonsaturating K(o)(+), DeltaKESYY induced an inward flow of Na(+) through Na/K pumps at negative potentials. Guanidinium(+) can also permeate truncated pumps, whereas N-methyl-D-glucamine cannot. Because guanidinium(o)(+) can also traverse normal Na/K pumps in the absence of both Na(o)(+) and K(o)(+) and can also inhibit Na/K pump currents in a Na(+)-like voltage-dependent manner, we conclude that the normal pathway transited by the first externally released Na(+) is large enough to accommodate guanidinium(+).

20 October 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
IRIan M. Ratheal
Ian M. Ratheal
GVGail K. Virgin
Gail K. Virgin
HYHaibo Yu
Haibo Yu
BRBenoît Roux
Benoît Roux
CGCraig Gatto
Craig Gatto
PAPablo Artigas
Pablo Artigas
The Na/K pump is a P-type ATPase that exchanges three intracellular Na + ions for two extracellular K + ions through the plasmalemma of nearly all animal cells. The mechanisms involved in cation selection by the pump's ion-binding sites (site I and site II bind either Na + or K + ; site III binds only Na + ) are poorly understood. We studied cation selectivity by outward-facing sites (high K + affinity) of Na/K pumps expressed in Xenopus oocytes, under voltage clamp. Guanidinium + , methylguanidinium + , and aminoguanidinium + produced two phenomena possibly reflecting actions at site III: ( i ) voltage-dependent inhibition (VDI) of outwardly directed pump current at saturating K + , and ( ii ) induction of pump-mediated, guanidinium-derivative–carried inward current at negative potentials without Na + and K + . In contrast, formamidinium + and acetamidinium + induced K + -like outward currents. Measurement of ouabain-sensitive ATPase activity and radiolabeled cation uptake confirmed that these cations are external K + congeners. Molecular dynamics simulations indicate that bound organic cations induce minor distortion of the binding sites. Among tested metals, only Li + induced Na + -like VDI, whereas all metals tested except Na + induced K + -like outward currents. Pump-mediated K + -like organic cation transport challenges the concept of rigid structural models in which ion specificity at site I and site II arises from a precise and unique arrangement of coordinating ligands. Furthermore, actions by guanidinium + derivatives suggest that Na + binds to site III in a hydrated form and that the inward current observed without external Na + and K + represents cation transport when normal occlusion at sites I and II is impaired. These results provide insights on external ion selectivity at the three binding sites.